User profiles for L Montemurro

Luigi Taranto Montemurro

Brigham and Women's Hospital, Boston, MA, USA
Verified email at bwh.harvard.edu
Cited by 3481

[HTML][HTML] MYCN impact on high-risk neuroblastoma: from diagnosis and prognosis to targeted treatment

D Bartolucci, L Montemurro, S Raieli, S Lampis… - Cancers, 2022 - mdpi.com
Simple Summary Neuroblastoma is one of the most diffuse and the deadliest cancer in
children. While many advances have been made in the last few decades to improve patients’ …

The late follow-up of chronic sarcoid patients previously treated with corticosteroids.

G Rizzato, L Montemurro, P Colombo - Sarcoidosis, vasculitis, and …, 1998 - europepmc.org
Methods We have retrospectively examined the charts of 702 consecutive patients with
histologically proven sarcoidosis, first seen in the Milan Sarcoidosis Clinic in the period October …

[HTML][HTML] Reboxetine plus oxybutynin for OSA treatment: a 1-week, randomized, placebo-controlled, double-blind crossover trial

…, LT Montemurro, D Rosa, S Vicini, M Marconi, L Zanotti… - Chest, 2022 - Elsevier
… In their project, Taranto-Montemurro et al 11 evaluated a combination of atomoxetine 80 mg
and oxybutynin 5 mg (ato-oxy) in a single-night study. The ato-oxy combination reduced the …

Inverse relationship of subjective daytime sleepiness to sympathetic activity in patients with heart failure and obstructive sleep apnea

LT Montemurro, JS Floras, PJ Millar, T Kasai… - Chest, 2012 - Elsevier
… Financial/nonfinancial disclosures: The authors have reported to CHEST the following
conflicts of interest: Dr Taranto Montemurro is supported by fellowships from the Chair of …

[HTML][HTML] Safety and heart rate changes in Covid-19 patients treated with Remdesivir

…, IF Bottalico, A Centola, L Montemurro… - International Journal of …, 2021 - Elsevier
Objectives Limited data are available regarding the occurrence and the extent of cardiac
rhythm disturbances in patients with COVID-19 treated with Remdesivir. Methods We present a …

Efficacy of a three day course of azithromycin in moderately severe community-acquired pneumonia

G Rizzato, L Montemurro, P Fraioli… - European …, 1995 - Eur Respiratory Soc
This study was designed to evaluate the efficacy of a 3 day course of azithromycin in low to
moderately severe community-acquired pneumonia. Forty patients with low to moderately …

Bile duct injuries during laparoscopic cholecystectomy: a 1994–2001 audit on 13,718 operations in the area of Rome

…, M Catarci, E Santoro, L Montemurro… - Surgical Endoscopy And …, 2004 - Springer
Background Bile duct injuries (BDIs) during laparoscopic cholecystectomy (LC) still are
reported with greater frequency than during open cholecystectomy (OC). Methods In 1999, a …

A novel MYCN-specific antigene oligonucleotide deregulates mitochondria and inhibits tumor growth in MYCN-amplified neuroblastoma

L Montemurro, S Raieli, S Angelucci, D Bartolucci… - Cancer research, 2019 - AACR
… Antigen retrieval was performed by heat processing in 1 mmol/L EDTA, pH 8, for N-Myc
antibody, and in 10 mmol/L citrate pH 6 for TRAP1. The slides were blocked with 10% BSA in …

Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients

L Montemurro, G Schiraldi, P Fraioli, G Tosi… - Calcified tissue …, 1991 - Springer
The aim of this study was to evaluate the usefulness of salmon calcitonin (sCT) in preventing
corticosteroid-induced osteoporosis. Three groups of patients with sarcoidosis requiring …

[HTML][HTML] MYCN Drives a Tumor Immunosuppressive Environment Which Impacts Survival in Neuroblastoma

…, S Lampis, C Amadesi, L Montemurro… - Frontiers in …, 2021 - frontiersin.org
A wide range of malignancies presents MYCN amplification (MNA) or dysregulation. MYCN
is associated with poor prognosis and its over-expression leads to several dysregulations …